Follow-up of Prostate Carcinoma with Serial Bone Scanning Using Cyclotron-Produced 18-Fluorine

Carcinoma of the prostate presents one of the major problems in urology. It has the highest incidence of all urogenital neoplasms in the male and is responsible for over 4000 deaths annually in the United Kingdom. Even when the diagnosis has been established there remain two important considerations in the management of these patients: (1) assessment of the extent of the disease to enable precise staging and (2) a reliable and accurate method of evaluating the progression of the disease or response to treatment in the absence of clinical symptoms and signs.